Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|September 2, 2008
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trialKim Fox, Ian Ford, P Gabriel Steg, et al.
European Heart Journal|September 12, 2018
Can we remove scar and fibrosis from adult human myocardium?Ali Vazir, Kim Fox, Joseph Westaby, et al.
American Heart Journal|October 23, 2023
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)Kevin R Bainey, David A Wood, Matthias Bossard, et al.
European Heart Journal|October 11, 2005
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable anginaJean-Claude Tardif, Ian Ford, Michal Tendera, et al.
Lancet (London, England)|August 15, 2006
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trialsGilles R Dagenais, Janice Pogue, Kim Fox, et al.
Lancet (London, England)|September 2, 2008
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trialKim Fox, Ian Ford, P Gabriel Steg, et al.
Journal of Analytical Toxicology|August 23, 2019
Validation of a High-throughput Screening and Quantification Method for the Determination of Gabapentinoids in Blood Using a Combination of LC-TOF-MS and LC-MS-MSHilda De La Vega, Kim Fox, Justine Pardi, et al.
European Heart Journal|September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trialKim Fox, Ian Ford, Ph Gabriel Steg, et al.
The New England Journal of Medicine|September 2, 2014
Ivabradine in stable coronary artery disease without clinical heart failureKim Fox, Ian Ford, Philippe Gabriel Steg, et al.
European Heart Journal|September 20, 2015
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY studyKim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Pageof 8